Coronary Physiology Clinical Trial Update and Review

42 views | 09 Nov 2020
Simple Education

899 videos

Updates into the latest updates in coronary interventions

Speakers
User Dr. Andrew Sharp uploaded avatar

Dr Sharp qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal...

Read More
User Dr. Justin Davies uploaded avatar

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of IFR, and clinical academic and consultant...

Read More
User Ricardo Petraco uploaded avatar

Dr Ricardo Petraco is a NIHR Lecturer in interventional Cardiology at Imperial College London, performing his...

Read More
User Dr. Sukh Nijjer uploaded avatar

Dr. Nijjer is a Consultant Cardiologist and Senior Clinical Lecturer at Imperial College London. He works at both the...

Read More
Join the conversation
Latest comments
Initials SS of SATYAJIT SINGH SS
Assoc. Prof. SATYAJIT SINGH
Consultant/Attending

25% of patients continue to have angina despite PCI. So, there's more to do for the Rx rather than cosmetically correcting the lesion

Initials SS of SATYAJIT SINGH SS
Assoc. Prof. SATYAJIT SINGH
Consultant/Attending

DEFINE FLOW study is really an eye-opener with lot of clinical implications. Even after revascularisation, if FFR < 0.80 and CFR < 2 , it portends a poor prognosis. If FFR > 0.80 post revasc and CFR < 2 , again its a suboptimal result.
Great hypothesis generating study